medigraphic.com
SPANISH

Revista Mexicana de Cirugía Endoscópica

ISSN 1665-2576 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 1

<< Back Next >>

Rev Mex Cir Endoscop 2011; 12 (1)

Laparoscopic gastric bypass versus laparoscopic vertical sleeve gastrectomy. Short-term results at an obesity clinic of the Mexico City government

Rodríguez AA, Ponce LM, Spaventa A, Liceaga A, Castañeda M, Pérez R, Romay K, Campos F
Full text How to cite this article

Language: Spanish
References: 30
Page: 15-22
PDF size: 75.91 Kb.


Key words:

Laparoscopic gastric Bypass, laparoscopic sleeve gastrectomy, comparison.

ABSTRACT

Introduction: Mexico occupies the second place worldwide in obesity, for this reason the government of Mexico City created the first clinic for surgical treatment of these patients. The most frequently used procedures are Laparoscopic Roux in Y Gastric Bypass (LRYGB) and Laparoscopic Sleeve Gastrectomy (LSG). The first proven to be safe and effective, with good long term results, and the second relatively easy to perform with good short term results. There are very few studies, none in Mexico, that compare these procedures. Objective: The objective of the present study is to describe and compare the results we obtained during the first year of experience at this clinic. Methods: From March 2009 to April 2010, 61 patients were operated. LRYGB (n = 40) and LSG (n = 21). We compared age, gender, BMI, morbidity, comorbidity outcome, operative time, length of stay, complications and percentage of excess body weight loss during an average follow up period of one year. Results: Difference in age, gender, morbidity and length of stay was not statistically significant. Preoperative BMI was higher in LSG patients. There was no statistical difference in remission of diabetes or hypertension, however LRYGB patients showed significant remission of mixed dyslipidemia, as well as greater loss of mean excess body weight after a 1 year mean follow up, 70.2 ± 19 for LRYGB group vs 41 ± 10 for LSG group (p = 0.00029383). The rate of complications for LRYGB patients 27.5 vs 24% in LSG patients. We had no mortality in either of the groups. Conclusions: LRYGB was more effective for short term loss of excess body weight, as well as remission of mixed dyslipidemia. The complications we experienced were relatively high in both groups, yet very similar to results of initial cases of bariatric procedures published in worldwide literature.


REFERENCES

  1. World Health Organization. Obesity: Preventing and managing of the global epidemic. Report of a WHO consultation presented at: the world health organization; 1997; Geneva, Switzerland. Publication WHO/NUT/NCD/98.1.

  2. Olaiz FG, Rivera DJ, Shamah LT, Rojas R, Villalpando HS, Hernández AM, Sepúlveda AJ. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

  3. Secretaría de Salud. Salud: México 2001-2005. México, D.F.: Secretaría de Salud, 2006.

  4. Consensus Development Conference Panel. NIH Conference. Gastrointestinal surgery for severe obesity. Ann Intern Med 1991; 115: 956-961.

  5. Balsiger BM, Luque-de León E, Sarr MG. Concise review for primary-care physicians. Surgical treatment of obesity: Who is appropiate candidate? Mayo Clin Proc 1997; 72: 551-558.

  6. American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) Obesity Task Force. AACE/ACE Position Statements on the Prevention, Diagnosisand Treatment of Obesity (1998 Revision). Endocr Pract 1998; 4: 297-350.

  7. Presutti RJ, Gorman RS, Swain JM. Primary care perspective on bariatric surgery. Mayo Clin Proc 2004; 79: 1158-1166.

  8. Leyba JL, Navarrete AS, Navarrete LS. Laparoscopic Rouxen- Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg 2010: DOI 10.1007/s11695-010- 0279-8.

  9. Buchwald H, Williams SE. Bariatric surgery world wide 2003. Obes Surg 2004; 14: 1157–64.

  10. Picot J, Jones J, Colquitt JL et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 41.

  11. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: A systematic review and metaanalysis. JAMA 2004; 292: 1724–37.

  12. Søvik TT, Aasheim ET, Kristinsson J et al. Establishing laparoscopic Roux-en-Y gastric bypass: Perioperative outcome and characteristics of the learning curve. Obes Surg 2009; 19: 158–65.

  13. Stephens DJ, Saunders JK, Belsley S et al. Short-term outcomes for super-super obese (BMI > or = 60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastricbypass, and open tubular gastric bypass. Surg Obes Relat Dis 2008; 4: 408–15.

  14. Mognol P, Chosidow D, Marmuse J. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 2005; 15: 1030–3.

  15. Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc 2007; 21: 1810–6.

  16. Himpens J, Dapri G, Cadiere G. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16: 1450–6.

  17. Han MS, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg 2005; 15: 1469-75.

  18. Moy J, Pomp A, Dakin A et al. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg 2008; 196: e56–9.21. Schauer P, Ikramuddin S, Gourash W et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Annals of Surgery 2000; 232: 515–529.

  19. Papailiou J, Konstantinos A, Konstantinos G et al. Morbid obesity and sleeve gastrectomy: How does it work? Obes Surg 2010; 20: 1448–1455.

  20. Wittgrove AC, Clark GW, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: Technique and results in 75 patients with 3-30 months follow-up. Obes Surg 1996; 6: 500-504.

  21. Schauer P, Ikramuddin S, Gourash W et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Annals of Surgery 2000; 232: 515–529.

  22. Higa K, Boone K, Ho T, Davies O. Laparoscopic Roux-en- Y gastric bypass for morbid obesity. Arch Surg 2000; 135: 1029-1034.

  23. Herrera M, Fajardo R, Lajous M et al. Derivación gastroyeyunal laparoscópica en obesidad mórbida. Experiencia inicial en el INCMNSZ. Asociación Mexicana de Cirugía Endoscópica, A.C. 2001; 2: 127-133.

  24. Herrera M, Romero M, Lerman I, Pantoja J, Sierra M et al. Bypass gástrico laparoscópico en Y de Roux en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Rev Invest Clin 2009; 63: 186-193.

  25. Tello-Mendoza T, Vergara-López A, Montoya-Ramírez J, Campos-Barrera E, Guillén-González M. Comparación del estado metabólico antes y después de la cirugía bariátrica en pacientes del Centro Médico Nacional 20 de Noviembre. Revista de Endocrinología y Nutrición 2009; 17: 107-114.

  26. Nguyen NT, Rivers R, Wolfe BM. Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg 2003; 197: 548-55; discussion 555-7.

  27. Frezza E, Reddy S, Gee L, Wachtel M. Complications after sleeve gastrectomy for morbid obesity. Obes Surg 2009; 19: 684–687.

  28. Hammoui N, Anthone GJ, Kaufman HS et al. Sleeve gastrectomy in the high-risk patient. Obes Surg 2006; 16: 1445–9.

  29. Catheline JM, Cohen R, Khochtali I et al. Treatment of super morbid obesity by sleeve gastrectomy. Presse Med 2006; 35: 383-7.

  30. Milone L, Strong V, Gagner M. Laparoscopic vertical sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > 50). Obes Surg 2005; 15: 612-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cir Endoscop. 2011;12